<?xml version="1.0" encoding="UTF-8"?>
<collection>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd http://dublincore.org/schemas/xmls/qdc/dcterms.xsd"><dc:language>eng</dc:language><dc:creator>Hoban, Daryl J.</dc:creator><dc:creator>Reinert, Ralf René</dc:creator><dc:creator>Bouchillon, Samuel K.</dc:creator><dc:creator>Dowzicky, Michael J.</dc:creator><dc:title>Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004-2013</dc:title><dc:source>Annals of clinical microbiology and antimicrobials 14, 27 (2015). doi:10.1186/s12941-015-0085-1</dc:source><dc:type>info:eu-repo/semantics/article</dc:type><dc:type>info:eu-repo/semantics/publishedVersion</dc:type><dc:publisher>Biomed Central</dc:publisher><dc:date>2015</dc:date><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:coverage>DE</dc:coverage><dc:identifier>https://publications.rwth-aachen.de/record/566895</dc:identifier><dc:identifier>https://publications.rwth-aachen.de/search?p=id:%22RWTH-CONV-091771%22</dc:identifier><dc:audience>Researchers</dc:audience><dc:relation>info:eu-repo/semantics/altIdentifier/issn/1476-0711</dc:relation><dc:relation>info:eu-repo/semantics/altIdentifier/wos/WOS:000354928900001</dc:relation><dc:relation>info:eu-repo/semantics/altIdentifier/pmid/pmid:25958201</dc:relation><dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.18154/RWTH-CONV-091771</dc:relation><dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1186/s12941-015-0085-1</dc:relation></oai_dc:dc>

</collection>